Search for: "Barr Laboratories IncĀ " Results 21 - 40 of 166
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
4 Nov 2007, 7:03 pm
Barr Laboratories, Inc. et al. 2:07-cv-05256; filed October 31, 2007 in the District Court... [read post]
15 Jul 2007, 6:11 pm
Barr Laboratories Inc. et al.1:07-cv-00432; filed July 11, 2007 in... [read post]
30 Jan 2013, 8:22 am by Mandour & Associates
Barr Laboratories, Inc. and Sandoz, Inc. were found by the lower court to not have sufficiently proven their claims that Allergan’s patent was invalid due to prior art and obviousness. [read post]
9 Oct 2009, 9:11 am
PLIVA-HRVATSKA d.o.o, PLIVA d.d., Barr Laboratories Inc., Barr Pharmaceuticals Inc., Barr Pharmaceuticals, LLC, et al. [read post]
20 Mar 2014, 5:34 pm
(“Alcon”) appeals from the final judgments of the United States District Court for the District of Delaware finding that Barr Laboratories, Inc. [read post]
1 Dec 2009, 9:45 am by Karen E. Keller
Barr Pharmaceuticals, Inc., Barr Pharmaceuticals, LLC and Barr Laboratories Inc. [read post]
16 Aug 2009, 3:23 am
Yasmin and Yaz are two types of birth control oral contraceptive pills manufactured by Bayer Healthcare, and the generic, Ocella, is marketed and distributed by Barr Laboratories, Inc. [read post]
6 Feb 2013, 12:00 am
Barr Labs the Federal Circuit affirmed a decision by the District of Delaware finding that Barr Laboratories, Inc. and Sandoz Inc. had infringed a patent owned by Allergen, Inc., and finding the patent-in-suit valid. [read post]
17 Jan 2007, 1:23 pm
On Wednesday, December 13, 2006, Celgene Corp. announced that it had received notification from Barr Laboratories, Inc. that Barr had filed an ANDA for generic thalidomide, 200 mg tablets, sold by Celgene under the brand name Thalomid. [read post]
31 Oct 2011, 7:00 am by Joshua Matz
Salazar (the Endangered Species Act), Barr Laboratories v. [read post]
4 Mar 2013, 2:20 pm by Tom Lamb
From the Yasmin™ / YAZ™ part of the Product-Related Litigation section of the drug company's most recent Annual Report, which was filed in late February 2013: Claimants allege that they have suffered personal injuries, some of them fatal, from the use of Bayer’s drospirenone-containing oral contraceptive products such as Yasmin™ and / or YAZ™ or from the use of Ocella™ and / or Gianvi™, generic versions of Yasmin™ and YAZ™,… [read post]